PALISADE BIO, INC. — Director's Dealing 2013

Apr 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2013-03-28

Reporting Person: JOHE KARL (Director, Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-28	Common Stock Purchase Option	$1.12	A	592219	Acquired	2023-03-28	Common Stock (592219)	Direct

Footnotes

F1: Right to buy.

F2: Represents Reporting Person's Long Term Incentive Grant for 2012. The options vests quarterly over 3 years subject to accelerated vesting upon the occurance of certain events. The term of the options is 10 years.